782 related articles for article (PubMed ID: 26602621)
1. A Review of Evidence-Based Care of Symptomatic Trichomoniasis and Asymptomatic Trichomonas vaginalis Infections.
Meites E; Gaydos CA; Hobbs MM; Kissinger P; Nyirjesy P; Schwebke JR; Secor WE; Sobel JD; Workowski KA
Clin Infect Dis; 2015 Dec; 61 Suppl 8(Suppl 8):S837-48. PubMed ID: 26602621
[TBL] [Abstract][Full Text] [Related]
2. Diagnosis and Management of Trichomonas vaginalis: Summary of Evidence Reviewed for the 2021 Centers for Disease Control and Prevention Sexually Transmitted Infections Treatment Guidelines.
Kissinger PJ; Gaydos CA; Seña AC; Scott McClelland R; Soper D; Secor WE; Legendre D; Workowski KA; Muzny CA
Clin Infect Dis; 2022 Apr; 74(Suppl_2):S152-S161. PubMed ID: 35416973
[TBL] [Abstract][Full Text] [Related]
3. Trichomonas vaginalis in selected U.S. sexually transmitted disease clinics: testing, screening, and prevalence.
Meites E; Llata E; Braxton J; Schwebke JR; Bernstein KT; Pathela P; Asbel LE; Kerani RP; Mettenbrink CJ; Weinstock HS
Sex Transm Dis; 2013 Nov; 40(11):865-9. PubMed ID: 24113409
[TBL] [Abstract][Full Text] [Related]
4. Added benefit of nucleic acid amplification testing for the diagnosis of Trichomonas vaginalis among men and women attending a sexually transmitted diseases clinic.
Muzny CA; Blackburn RJ; Sinsky RJ; Austin EL; Schwebke JR
Clin Infect Dis; 2014 Sep; 59(6):834-41. PubMed ID: 24928292
[TBL] [Abstract][Full Text] [Related]
5. [Therapeutic aspects of trichomoniasis].
Vukićević J; Jankicević J
Srp Arh Celok Lek; 2003; 131(3-4):156-61. PubMed ID: 14608880
[TBL] [Abstract][Full Text] [Related]
6. Trichomoniasis: the "neglected" sexually transmitted disease.
Meites E
Infect Dis Clin North Am; 2013 Dec; 27(4):755-64. PubMed ID: 24275268
[TBL] [Abstract][Full Text] [Related]
7. Disparities in adherence to retesting guidelines in women with Trichomonas vaginalis infection.
Getaneh FW; Oliveira CR; Pathy S; Sheth SS
Am J Obstet Gynecol; 2023 Sep; 229(3):284.e1-284.e10. PubMed ID: 37393012
[TBL] [Abstract][Full Text] [Related]
8. Trichomoniasis and its treatment.
Nanda N; Michel RG; Kurdgelashvili G; Wendel KA
Expert Rev Anti Infect Ther; 2006 Feb; 4(1):125-35. PubMed ID: 16441214
[TBL] [Abstract][Full Text] [Related]
9. Chemotherapeutic options for the treatment of human trichomoniasis.
Küng E; Fürnkranz U; Walochnik J
Int J Antimicrob Agents; 2019 Feb; 53(2):116-127. PubMed ID: 30612993
[TBL] [Abstract][Full Text] [Related]
10. Trichomoniasis.
Van Gerwen OT; Opsteen SA; Graves KJ; Muzny CA
Infect Dis Clin North Am; 2023 Jun; 37(2):245-265. PubMed ID: 37005163
[TBL] [Abstract][Full Text] [Related]
11. Vulvovaginitis: screening for and management of trichomoniasis, vulvovaginal candidiasis, and bacterial vaginosis.
van Schalkwyk J; Yudin MH;
J Obstet Gynaecol Can; 2015 Mar; 37(3):266-274. PubMed ID: 26001874
[TBL] [Abstract][Full Text] [Related]
12. Persistent and recurrent Trichomonas vaginalis infections: epidemiology, treatment and management considerations.
Seña AC; Bachmann LH; Hobbs MM
Expert Rev Anti Infect Ther; 2014 Jun; 12(6):673-85. PubMed ID: 24555561
[TBL] [Abstract][Full Text] [Related]
13. Prevention or treatment: the benefits of Trichomonas vaginalis vaccine.
Cudmore SL; Garber GE
J Infect Public Health; 2010; 3(2):47-53. PubMed ID: 20701891
[TBL] [Abstract][Full Text] [Related]
14. The clinical spectrum of Trichomonas vaginalis infection and challenges to management.
Muzny CA; Schwebke JR
Sex Transm Infect; 2013 Sep; 89(6):423-5. PubMed ID: 23543252
[TBL] [Abstract][Full Text] [Related]
15. Trichomonas vaginalis infection in male sexual partners: implications for diagnosis, treatment, and prevention.
Seña AC; Miller WC; Hobbs MM; Schwebke JR; Leone PA; Swygard H; Atashili J; Cohen MS
Clin Infect Dis; 2007 Jan; 44(1):13-22. PubMed ID: 17143809
[TBL] [Abstract][Full Text] [Related]
16. Trichomoniasis in teens: an update.
Huppert JS
Curr Opin Obstet Gynecol; 2009 Oct; 21(5):371-8. PubMed ID: 19491679
[TBL] [Abstract][Full Text] [Related]
17. United Kingdom National Guideline on the Management of Trichomonas vaginalis 2014.
Sherrard J; Ison C; Moody J; Wainwright E; Wilson J; Sullivan A
Int J STD AIDS; 2014 Jul; 25(8):541-9. PubMed ID: 24616117
[TBL] [Abstract][Full Text] [Related]
18. Utility of antimicrobial susceptibility testing in Trichomonas vaginalis-infected women with clinical treatment failure.
Bosserman EA; Helms DJ; Mosure DJ; Secor WE; Workowski KA
Sex Transm Dis; 2011 Oct; 38(10):983-7. PubMed ID: 21934577
[TBL] [Abstract][Full Text] [Related]
19. Changing sexually transmitted infection screening protocol will result in improved case finding for trichomonas vaginalis among high-risk female populations.
Roth AM; Williams JA; Ly R; Curd K; Brooks D; Arno J; Van Der Pol B
Sex Transm Dis; 2011 May; 38(5):398-400. PubMed ID: 21217417
[TBL] [Abstract][Full Text] [Related]
20. Screening for Trichomonas vaginalis in a Large High-Risk Population: Prevalence Among Men and Women Determined by Nucleic Acid Amplification Testing.
Schwebke J; Merriweather A; Massingale S; Scisney M; Hill C; Getman D
Sex Transm Dis; 2018 May; 45(5):e23-e24. PubMed ID: 29465684
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
